Search results for " CELL CARCINOMA"

showing 10 items of 477 documents

A Rare Case of Giant Basal Cell Carcinoma of the Abdominal Wall: Excision and Immediate Reconstruction with a Pedicled Deep Inferior Epigastric Arter…

2017

Patient: Female, 82 Final Diagnosis: Giant basal cell carcinoma Symptoms: Anemia Medication: — Clinical Procedure: — Specialty: Plastic Surgery Objective: Rare disease Background: Basal cell carcinoma (BCC) greater than 5 cm in diameter is called giant basal cell carcinoma (GBCC), or super giant basal cell carcinoma if it has a diameter larger than 20 cm. Giant BCC only accounts for 0.5% of BCCs and super giant BCC is exceedingly rare. On account of their rarity, there are no established guidelines for GBCC treatment. Case Report: We describe a peculiar case of an 82-year-old woman with a GBCC carcinoma of the lower abdominal wall. The tumor was surgically removed with ipsilateral inguinal …

medicine.medical_specialtySkin NeoplasmsPropeller FlapSettore MED/19 - Chirurgia Plastica030204 cardiovascular system & hematologyAbdominal wall03 medical and health sciencesRare Diseases0302 clinical medicineDIEP flapRare casemedicineCarcinomaHumansNeoplasm InvasivenessBasal cell carcinomagiant basal cell carcinomaAged 80 and overSystemic complicationbusiness.industryAbdominal WallDeep Inferior Epigastric ArteryArticlesGeneral Medicinemedicine.diseaseMultiple pathologiesSurgerymedicine.anatomical_structureCarcinoma Basal CellFemalebusinessPerforator FlapBasal Cell Carcinoma030217 neurology & neurosurgeryAmerican Journal of Case Reports
researchProduct

S2k guidelines for Merkel cell carcinoma (MCC, neuroendocrine carcinoma of the skin) – update 2018

2019

Merkel cell carcinoma (MCC, ICD-O M8247 / 3) is a rare malignant primary skin tumor with epithelial and neuroendocrine differentiation. The neoplastic cells share many morphological, immunohistochemical and ultrastructural characteristics with Merkel cells of the skin. The diagnosis of MCC is rarely made on clinical grounds. Histological and immunohistochemical studies are usually required to confirm the clinical suspicion. Given the frequent occurrence of occult lymph node metastasis, sentinel lymph node biopsy should be performed once distant metastasis has been ruled out by cross-sectional imaging. Primary tumors without evidence of organ metastases are treated with complete surgical exc…

medicine.medical_specialtySkin Neoplasmsmedicine.medical_treatmentSentinel lymph nodeMedizinAntineoplastic AgentsDermatologyNeuroendocrine differentiation030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineBiopsyCarcinomaHumansMedicineNeoadjuvant therapyAgedNeoplasm Stagingmedicine.diagnostic_testbusiness.industryMerkel cell carcinomaPrognosismedicine.diseaseNeoadjuvant TherapyCarcinoma Merkel CellRadiation therapymedicine.anatomical_structureLymphatic MetastasisImmunotherapyRadiologyNeoplasm Recurrence LocalCognition DisordersbusinessMerkel cell
researchProduct

An innervated retroauricular skin flap for total earlobule reconstruction.

2003

In this article, the authors describe a technique for total earlobule reconstruction in a patient who underwent earlobule excision for basal cell carcinoma. The reconstruction was by means of an innervated retroauricular skin flap, folded double. The flap presented preserved skin sensitivity over all the reconstructed area, which is compromised by those techniques using a cranially or medially based flap which lead to the reconstruction of an insensible earlobule. This is a very important aspect of this technique, especially for those who wear pendant earrings, since a non-sensitive lobule would be more vulnerable to traumas causing laceration. In addition, it allows a good aesthetic result…

medicine.medical_specialtySkin flapScarsEar reconstructionSkin sensitivitySurgical FlapsmedicineHumansBasal cell carcinomaEarlobule Retroauricular skinInnervated flap Ear reconstruction Basal cell carcinomaEar ExternalEar NeoplasmsXeroderma Pigmentosumbusiness.industryAnatomyMiddle AgedPlastic Surgery Proceduresmedicine.diseaseSurgeryTreatment OutcomeOtorhinolaryngologyPatient SatisfactionEar lobeSurgeryFemalemedicine.symptombusinessBritish journal of plastic surgery
researchProduct

Brief S2k guidelines - Cutaneous squamous cell carcinoma

2013

medicine.medical_specialtyText miningCutaneous squamous cell carcinomabusiness.industryMEDLINECarcinomaMedicineDermatologybusinessmedicine.diseaseDermatologyJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

Radical Cystectomy - Often Too Late?

1987

From 1967 to 1985, 246 cystectomies for treatment of transitional cell carcinoma of the urinary bladder were performed. Perioperative mortality decreased from 15% in the early years to 0% in 1985. Preoperative radiotherapy was not given. Patients who underwent cystectomy immediately following the diagnosis of invasive bladder carcinoma had a significantly better prognosis than those having cystectomy after recurrence of a transurethrally resected invasive carcinoma in spite of identical G and T criteria. A total of 26 patients who were cystectomized because of tumor recurrence after definitive radiotherapy (salvage cystectomy) represented the group with the worst prognosis: they had a 5-yea…

medicine.medical_specialtyTime FactorsUrologymedicine.medical_treatmentUrologyCystectomyMethodsCarcinomamedicineAdjuvant therapyHumansSurvival rateCarcinoma Transitional CellUrinary bladderBladder cancerbusiness.industryPerioperativeMiddle AgedPrognosismedicine.diseaseSurgerymedicine.anatomical_structureTransitional cell carcinomaUrinary Bladder NeoplasmsNeoplasm Recurrence LocalbusinessEuropean Urology
researchProduct

Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis

2001

Objective  To determine the need to standardize the number and location of lymph nodes to be removed during radical cystectomy in patients with invasive bladder carcinoma. Patients and methods  The pelvic lymph nodes from 447 patients (mean age 62.8 years) who underwent radical cystectomy between 1986 and 1997 were evaluated. The number of lymph nodes was correlated with the depth of invasion of the primary tumour (pT), occurrence of nodal metastases, clinical outcome, the operating surgeons and the pathologists dissecting the nodes. Results  The clinical follow-up was available for 302 patients (mean follow-up 38.7 months). The mean (range) number of lymph nodes removed was 14.7 (1–46). Th…

medicine.medical_specialtyUrinary bladderBladder cancerbusiness.industryUrologymedicine.medical_treatmentmedicine.diseaseSurgeryCystectomyTransitional cell carcinomamedicine.anatomical_structuremedicineCarcinomaLymphadenectomyLymphRadiologybusinessLymph nodeBJU International
researchProduct

Intravesical Treatment of Superficial Urinary Bladder Tumours with Adriamycin

1980

Personal experience resulted in the observation that intravesical Adriamycin (ADM) is effective in some patients with multiple or diffuse papillary bladder tumours. A review of the literature shows that similar results have been obtained elsewhere, especially in Japan and Sweden. The response rate was higher if single doses of at least 50 mg were employed. Intravesical instillations of ADM appear to be valuable also in the treatment of carcinoma in situ and in prophylactic treatment after transurethral resection (TUR) of papillary bladder tumours.

medicine.medical_specialtyUrinary bladderbusiness.industryCarcinoma in situUrologymedicine.diseaseResectionNeck of urinary bladderTransitional cell carcinomaIntravesical treatmentmedicine.anatomical_structureIntravesical instillationmedicinebusinessProphylactic treatment
researchProduct

Electrochemical detection and screening of bladder cancer recurrence using direct electrochemical analysis of urine: A non-invasive tool for diagnosis

2018

Although detection of urothelial cell carcinoma (or bladder cancer, BC) can be performed via cytological, molecular and genetic marker tests on urine, cystoscopy, an invasive technique, still remains as the gold methodology in clinical practice. It is presented a non-invasive method for detecting BC recurrence consisting of a direct electrochemical test in urine combining voltammetric data at gold and glassy carbon electrodes. The diagnosis is based on the ratio between characteristic voltammetric features recorded for tryptophan, serotonin and melatonin and other related metabolites. The method was tested by means of a clinical trial with 30 patients diagnosed of bladder cancer and a two c…

medicine.medical_specialtyUrinary systemUrology02 engineering and technologyElectrochemical detectionUrineUrine010402 general chemistry01 natural sciencesUrothelial cell carcinomaMaterials ChemistrymedicineElectrochemistryElectrical and Electronic EngineeringInstrumentationBladder cancermedicine.diagnostic_testbusiness.industryNon invasiveBladder cancerMetals and AlloysCystoscopyNon-invasive diagnostic021001 nanoscience & nanotechnologyCondensed Matter Physicsmedicine.disease0104 chemical sciencesSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsClinical trial0210 nano-technologybusiness
researchProduct

Results of conservative treatment (transurethral resection plus adjuvant intravesical chemotherapy) in patients with primary T1, G3 transitional cell…

1996

Objectives. To evaluate a selected population of 50 consecutive patients with primary T1, G3 bladder transitional cell carcinoma in the absence of carcinoma in situ (Tis) treated with a bladder-sparing approach. Methods. Between January 1983 and December 1992, all patients were treated by transurethral resection (TUR) plus adjuvant intravesical chemotherapy over 1 year. In most cases, doxorubicin, epirubicin, and mitomycin were used alone or in combination. Results. At a mean follow-up period of 52 months (range, 18 to 126), 16 of 50 patients (32%) showed a recurrent superficial tumor. The recurrent lesion was of Stage T1 in 11 (22%) cases, but was a T1, G3 tumor only in 5 cases (10%). In 2…

medicine.medical_specialtyUrologymedicine.medical_treatmentPopulationAntineoplastic AgentsMitomycinsSettore MED/24 - UrologiaCystectomyUrethraCarcinomamedicineHumansBACILLUS CALMETTE-GUERINeducationEpirubicinNeoplasm StagingCarcinoma Transitional Celleducation.field_of_studyUrinary bladderBladder cancerbusiness.industryCarcinoma in situmedicine.diseaseCombined Modality TherapyCANCERSurgeryAdministration Intravesicalmedicine.anatomical_structureTransitional cell carcinomaUrinary Bladder NeoplasmsChemotherapy AdjuvantDoxorubicinSurgical Procedures OperativeNeoplasm Recurrence LocalbusinessFollow-Up StudiesEpirubicinmedicine.drugUrology
researchProduct

What is the accuracy of the surgical guide in the planning of orthognathic surgeries? A systematic review.

2021

BACKGROUND To investigate the true accuracy of the surgical guide in the planning of orthognathic surgeries, which are performed worldwide. MATERIAL AND METHODS A systematic search was conducted in the PubMed database, Web of science, Scopus and Embase, covering August 2020 to January 2021. Studies that included patients with dentofacial deformity including anteroposterior, vertical and asymmetry problems who were undergoing an orthognathic surgery procedure were included; QUADAS-2 was used to determine the risk of bias by analyzing the quality of the studies. A PRISMA (flowchart) was created to show the study selection, keywords, nomination processes, and inclusion and exclusion criteria. …

medicine.medical_specialtyWeb of sciencemedicine.medical_treatmentOrthognathic surgeryDentofacial DeformityImaging Three-DimensionalmedicineHumansMedical physicsGeneral DentistryUNESCO:CIENCIAS MÉDICASoral squamous cell carcinoma (oscc)business.industryOrthognathic Surgical ProceduresOrthognathic Surgeryvitamin doral canceroral potentially malignant disorders (opmds)OtorhinolaryngologyVirtual planningSurgery Computer-AssistedInclusion and exclusion criteriaPrinting Three-DimensionalComputer-Aided DesignSurgerybusinessSystematic searchMedicina oral, patologia oral y cirugia bucal
researchProduct